Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2006 Jun 3;9(1):50–55. doi: 10.1016/S1045-1870(98)80051-4

Epidemiology, pathogenesis, and treatment of the common cold

J Owen Hendley 1,*
PMCID: PMC7129474  PMID: 32288450

Abstract

The common cold is an acute illness of the upper respiratory tract caused by a virus acquired from another person. Some viruses that produce colds are capable of infecting an individual repeatedly (eg, respiratory syncytial virus); others, with many serotypes (eg, rhinovirus), infect only once. The sustained epidemic of colds that occurs annually during September through April is explained by successive waves of different viruses moving through a community. The peak incidence of colds occurs in preschool children, who typically sustain at least one illness per month during the epidemic period. Clinical manifestations of colds are largely subjective in adults. Colds in preschoolers differ from those in adults as follows: (1) fever is common in children during the first 3 days; (2) colored nasal secretions may be the only indication of nasal involvement in children; and (3) colds in children last 10 to 14 days, as compared with a duration of less than a week in adults. The paranasal sinuses and the middle ear cavities are commonly involved during viral colds in adults (and presumably in children) in the absence of bacterial superinfection. Cold symptoms are due to the host's response to the virus rather than to destruction of the nasal mucosa. Viral infection of a very limited portion of the nasal epithelium results in an influx of polymorphonuclear leukocytes, cytokine release, and a vascular leak. Colds are self-limited illnesses. Therefore, in the absence of adequate blinding of controls, ineffective treatments erroneously may be considered efficacious. None of the medicines used for symptom relief in colds is curative.

References

  • 1.Dingle JH, Badger GF, Jordan WS. Press of Case Western Reserve University; Cleveland, OH: 1964. Illness in the home. [Google Scholar]
  • 2.Glezen WP, Denny FW. Epidemiology of acute lower respiratory disease in children. N Engl J Med. 1973;288:498–505. doi: 10.1056/NEJM197303082881005. [DOI] [PubMed] [Google Scholar]
  • 3.Hendley JO, Gwaltney JM., Jr Mechanisms of transmission of rhinovirus infections. Epidemiol Rev. 1988;10:242–258. [PubMed] [Google Scholar]
  • 4.Hall CB, Douglas RG, Schnabel KC. Infectivity of respiratory syncytial virus by various routes of inoculation. Infect Immun. 1981;33:779–783. doi: 10.1128/iai.33.3.779-783.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Hendley JO, Wenzel RP, Gwaltney JM., Jr Transmission of rhinovirus colds by self-inoculation. N Engl J Med. 1973;288:1361–1364. doi: 10.1056/NEJM197306282882601. [DOI] [PubMed] [Google Scholar]
  • 6.Moser MR, Bender TR, Margolis HS. An outbreak of influenza aboard a commercial airline. Am J Epidemiol. 1979;110:1–6. doi: 10.1093/oxfordjournals.aje.a112781. [DOI] [PubMed] [Google Scholar]
  • 7.Turner RB, Meschievitz CK, Streisand AC. Mechanism of transmission of coronavirus 229E in human volunteers. Clin Res. 1987;35:145. [Google Scholar]
  • 8.Hall CB, Douglas RG. Modes of transmission of respiratory syncytial virus. J Pediatr. 1981;99:100–103. doi: 10.1016/s0022-3476(81)80969-9. [DOI] [PubMed] [Google Scholar]
  • 9.Dick EC, Jennings LC, Mink KA. Aerosol transmission of rhinovirus colds. J Infect Dis. 1987;156:442–448. doi: 10.1093/infdis/156.3.442. [DOI] [PubMed] [Google Scholar]
  • 10.Gwaltney JM, Jr, Moskalski PB, Hendley JO. Hand-to-hand transmission of rhinovirus colds. Ann Intern Med. 1978;88:463–467. doi: 10.7326/0003-4819-88-4-463. [DOI] [PubMed] [Google Scholar]
  • 11.Gala CL, Hall CB, Schnabel KG. The use of eye-nose goggles to control nosocomial respiratory syncytial virus infection. JAMA. 1986;256:2706–2708. [PubMed] [Google Scholar]
  • 12.Gwaltney JM, Jr, Phillips CD, Miller RD. Computed tomographic study of the common cold. N Engl J Med. 1994;330:25–30. doi: 10.1056/NEJM199401063300105. [DOI] [PubMed] [Google Scholar]
  • 13.Elkhatieb A, Hipskind G, Woerner D. Middle ear abnormalities during natural rhinovirus colds in adults. J Infec Dis. 1993;168:618–621. doi: 10.1093/infdis/168.3.618. [DOI] [PubMed] [Google Scholar]
  • 14.Winther B, Brofeldt S, Christensen B. Light and scanning electron microscopy of nasal biopsy material from patients with naturally acquired common colds. Acta Otolaryngol (Stockh) 1984;97:309–318. doi: 10.3109/00016488409130994. [DOI] [PubMed] [Google Scholar]
  • 15.Winther B, Farr B, Turner RB. Histopathologic examination and enumeration of polymorphonuclear leukocytes in the nasal mucosa during experimental rhinovirus colds. Acta Otolaryngol (Stockh) 1984;413:19–24. doi: 10.3109/00016488409128537. (suppl) [DOI] [PubMed] [Google Scholar]
  • 16.Naclerio RM, Proud D, Lichtenstein LM. Kinins are generated during experimental rhinovirus colds. J Infect Dis. 1988;157:133–142. doi: 10.1093/infdis/157.1.133. [DOI] [PubMed] [Google Scholar]
  • 17.Winther B, Brofeldt S, Gronborg H. Study of bacteria in the nasal cavity and nasopharynx during naturally acquired common colds. Acta Otolaryngol (Stockh) 1984;98:315–320. doi: 10.3109/00016488409107569. [DOI] [PubMed] [Google Scholar]
  • 18.Turner RB, Hendley JO, Gwaltney JM., Jr Shedding of infected ciliated epithelial cells in rhinovirus colds. J Infect Dis. 1982;145:849–853. doi: 10.1093/infdis/145.6.849. [DOI] [PubMed] [Google Scholar]
  • 19.Bardin PG, Johnston SL, Sanderson G. Detection of rhinovirus infection of the nasal mucosa by oligonucleotide in situ hybridization. Am J Respir Cell Mol Biol. 1994;10:207–213. doi: 10.1165/ajrcmb.10.2.8110476. [DOI] [PubMed] [Google Scholar]
  • 20.Arruda E, Boyle TR, Winther B. Localization of human rhinovirus replication in the upper respiratory tract by in situ hybridization. J Infect Dis. 1995;171:1329–1333. doi: 10.1093/infdis/171.5.1329. [DOI] [PubMed] [Google Scholar]
  • 21.Winther B, Gwaltney JM, Jr, Hendley JO. Respiratory virus infection of monolayer cultures of human nasal epithelial cells. Am Rev Respir Dis. 1990;141:839–845. doi: 10.1164/ajrccm/141.4_Pt_1.839. [DOI] [PubMed] [Google Scholar]
  • 22.Turner RB. Rhinovirus infection of human embryonic lung fibroblasts induces the production of a chemoattractant for polymorpho-nuclear leukocytes. J Infect Dis. 1988;157:346–350. doi: 10.1093/infdis/157.2.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Turner RB. Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology; Orlando, FL: 1994. Elaboration of interleukin 8 (IL-8) from fibroblast (MRC-5) cells and human nasal epithelium in response to rhinovirus (RV) challenge, 1994. (abstr B43) [Google Scholar]
  • 24.Proud D. Proceedings I. Madrid, Spain, XVI European Congress of Allergology and Clinical Immunology (ECACI) 1995. Epithelial derived cytokines and the modulation by virus infection, 1995; pp. 357–362. [Google Scholar]
  • 25.Choi AMK, Jacoby DB. Influenza A infection induces interleukin-8 gene expression in human airway epithelial cells. FEBS Lett. 1992;309:327–329. doi: 10.1016/0014-5793(92)80799-m. [DOI] [PubMed] [Google Scholar]
  • 26.Noah TL, Becker S. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am J Physiol. 1993;265:L472–L478. doi: 10.1152/ajplung.1993.265.5.L472. [DOI] [PubMed] [Google Scholar]
  • 27.Noah TL, Henderson FW, Wortman IA. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis. 1995;171:584–592. doi: 10.1093/infdis/171.3.584. [DOI] [PubMed] [Google Scholar]
  • 28.Roseler S, Holtappels G, Wagenmann M. Elevated levels of interleukins IL 1β, IL-6 and IL-8 in naturally acquired viral rhinitis. Eur Arch Otolarhinolaryngol. 1995;252:S61–S63. doi: 10.1007/BF02484437. (suppl 1) [DOI] [PubMed] [Google Scholar]
  • 29.Proud D, Reynolds CJ, Lacapra S. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis. 1988;137:613–616. doi: 10.1164/ajrccm/137.3.613. [DOI] [PubMed] [Google Scholar]
  • 30.Heikkinen T, Ruuskanen O, Ziegler T. Short-term use of amoxicillin-clavulanate during upper respiratory tract infection for prevention of acute otitis media. J Pediatr. 1995;126:313–316. doi: 10.1016/s0022-3476(95)70569-4. [DOI] [PubMed] [Google Scholar]
  • 31.Sperber SJ, Hayden FG. Chemotherapy of rhinovirus colds. Antimicrob Agents Chemother. 1988;32:409–419. doi: 10.1128/aac.32.4.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Farr BM, Conner EM, Betts RF. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrob Agents Chemother. 1987;31:1183–1187. doi: 10.1128/aac.31.8.1183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Gustafson LM, Proud D, Hendley JO. Oral prednisone therapy in experimental rhinovirus infections. J Allergy Clin Immunol. 1996;97:1009–1014. doi: 10.1016/s0091-6749(96)80077-7. [DOI] [PubMed] [Google Scholar]
  • 34.Gwaltney JM., Jr Combined antiviral and antimediator treatment of rhinovirus colds. J Infect Dis. 1992;166:776–782. doi: 10.1093/infdis/166.4.776. [DOI] [PubMed] [Google Scholar]
  • 35.Hendley JO. The common colds. In: Bennet JC, Plum F, editors. Cecil Textbook of Medicine. ed 20. Saunders; Philadelphia, PA: 1996. pp. 1747–1749. [Google Scholar]

Articles from Seminars in Pediatric Infectious Diseases are provided here courtesy of Elsevier

RESOURCES